CoChat

Re-thinking the Etiological Framework of Neurodegeneration

Open access
Castillo, Ximena, Castro-Obregón, Susana, Gutiérrez-Becker, Benjamin, Gutiérrez-Ospina, Gabriel, Karalis, Nikolaos, Khalil, Ahmed A., Lopez-Noguerola, José Sócrates, Rodríguez, Liliana Lozano, Martínez-Martínez, Eduardo, Perez-Cruz, Claudia, Pérez-Velázquez, Judith, Piña, Ana Luisa, Rubio, Karla, García, Héctor Pedro Salazar, Syeda, Tauqeerunnisa, Vanoye-Carlo, America, Villringer, Arno, Winek, Katarzyna, Zille, Marietta · 2019 · Frontiers in Neuroscience
Cited by 79

The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.

Abstract

Neurodegenerative diseases are among the leading causes of disability and death worldwide. The disease-related socioeconomic burden is expected to increase with the steadily increasing life expectancy. In spite of decades of clinical and basic research, most strategies designed to manage degenerative brain diseases are palliative. This is not surprising as neurodegeneration progresses "silently" for decades before symptoms are noticed. Importantly, conceptual models with heuristic value used to study neurodegeneration have been constructed retrospectively, based on signs and symptoms already present in affected patients; a circumstance that may confound causes and consequences. Hence, innovative, paradigm-shifting views of the etiology of these diseases are necessary to enable their timely prevention and treatment. Here, we outline four alternative views, not mutually exclusive, on different etiological paths toward neurodegeneration. First, we propose neurodegeneration as being a secondary outcome of a primary cardiovascular cause with vascular pathology disrupting the vital homeostatic interactions between the vasculature and the brain, resulting in cognitive impairment, dementia, and cerebrovascular events such as stroke. Second, we suggest that the persistence of senescent cells in neuronal circuits may favor, together with systemic metabolic diseases, neurodegeneration to occur. Third, we argue that neurodegeneration may start in response to altered body and brain trophic interactions established via the hardwire that connects peripheral targets with central neuronal structures or by means of extracellular vesicle (EV)-mediated communication. Lastly, we elaborate on how lifespan body dysbiosis may be linked to the origin of neurodegeneration. We highlight the existence of bacterial products that modulate the gut-brain axis causing neuroinflammation and neuronal dysfunction. As a concluding section, we end by recommending research avenues to investigate these etiological paths in the future. We think that this requires an integrated, interdisciplinary conceptual research approach based on the investigation of the multimodal aspects of physiology and pathophysiology. It involves utilizing proper conceptual models, experimental animal units, and identifying currently unused opportunities derived from human data. Overall, the proposed etiological paths and experimental recommendations will be important guidelines for future cross-discipline research to overcome the translational roadblock and to develop causative treatments for neurodegenerative diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2019.00728

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 122 references

Research works printed but not linked: 213

  1. Andrade, 2014, The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms., Circ. Res., 114, 1453, 10.1161/circresaha.114.303211 · DOI · Paper page
  2. Anselmino, 2016, Transient cerebral hypoperfusion and hypertensive events during atrial fibrillation: a plausible mechanism for cognitive impairment., Sci. Rep., 6, 10.1038/srep28635 · DOI
  3. Arai, 1991, Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer’s disease and control subjects., Ann. Neurol., 30, 686, 10.1002/ana.410300509 · DOI · Paper page
  4. Ashley, 2018, Retrovirus-like gag protein arc1 binds RNA and traffics across synaptic boutons., Cell, 172, 262, 10.1016/j.cell.2017.12.022 · DOI · Paper page
  5. Ask, 2018, The neuro-immuno-senescence integrative model (NISIM) on the negative association between parasympathetic activity and cellular senescence., Front. Neurosci., 12, 10.3389/fnins.2018.00726 · DOI
  6. Avila-Nava, 2017, Food combination based on a pre-hispanic Mexican diet decreases metabolic and cognitive abnormalities and gut microbiota dysbiosis caused by a sucrose-enriched high-fat diet in rats., Mol. Nutr. Food Res., 61, 10.1002/mntr.201501023 · doi:10.1002/mntr.201501023
  7. Balusu, 2016, Identification of a novel mechanism of blood-brain communication during peripheral inflammation via choroid plexus-derived extracellular vesicles., EMBO Mol. Med., 8, 1162, 10.15252/emmm.201606271 · DOI · Paper page
  8. Banerjee, 2017, Stroke caused by atherosclerosis of the major intracranial arteries., Circ. Res., 120, 502, 10.1161/circresaha.116.308441 · DOI · Paper page
  9. Baothman, 2016, The role of gut microbiota in the development of obesity and diabetes., Lipids Health Dis., 15, 10.1186/s12944-016-0278-4 · DOI · Paper page
  10. Bhattacharjee, 2013, Alzheimer’s disease and the microbiome., Front. Cell Neurosci., 7, 10.3389/fncel.2013.00153 · DOI · Paper page
  11. Bilgel, 2019, Predicting time to dementia using a quantitative template of disease progression., Alzheimers Dement, 11, 205, 10.1016/j.dadm.2019.01.005 · DOI · Paper page
  12. Bloemen, 2010, Short chain fatty acids exchange: is the cirrhotic, dysfunctional liver still able to clear them?, Clin. Nutr., 29, 365, 10.1016/j.clnu.2009.10.002 · DOI
  13. Blum-Degen, 1995, Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?, J. Neural Transm. Suppl., 46, 139
  14. Bohnen, 2011, White matter lesions in Parkinson disease., Nat Rev Neurol, 7, 229, 10.1038/nrneurol.2011.21 · DOI · Paper page
  15. Braak, Staging of brain pathology related to sporadic Parkinson’s disease., Neurobiol. Aging, 24, 197, 10.1016/s0197-4580(02)00065-9 · DOI · Paper page
  16. Braak, Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen., J. Neural Transm., 110, 517, 10.1007/s00702-002-0808-2 · DOI · Paper page
  17. Broadwell, 1989, Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal., Acta Neuropathol., 79, 117, 10.1007/bf00294368 · DOI · Paper page
  18. Brouns, 2011, Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome., Eur. Neurol., 65, 23, 10.1159/000321965 · DOI
  19. Brown, 2005, Neurodegenerative diseases: an overview of environmental risk factors., Environ. Health Perspect., 113, 1250, 10.1289/ehp.7567 · DOI · Paper page
  20. Buerge, 2011, Lobar dementia due to extreme widening of virchow-robin spaces in one hemisphere., Case Rep. Neurol., 3, 136, 10.1159/000329267 · DOI
  21. Buga, 2013, Preclinical models of stroke in aged animals with or without comorbidities: role of neuroinflammation., Biogerontology, 14, 651, 10.1007/s10522-013-9465-0 · DOI
  22. Campbell, 2011, Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus., Clin. Ther., 33, 511, 10.1016/j.clinthera.2011.04.015 · DOI
  23. Cani, 2012, Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity., Gut Microbes, 3, 279, 10.4161/gmic.19625 · DOI · Paper page
  24. Carvalho, 2012, Metabolic alterations induced by sucrose intake and Alzheimer’s disease promote similar brain mitochondrial abnormalities., Diabetes Metab. Res. Rev., 61, 1234, 10.2337/db11-1186 · DOI
  25. Caviedes, 2017, Endothelial nitric oxide synthase is present in dendritic spines of neurons in primary cultures., Front. Cell Neurosci., 11, 10.3389/fncel.2017.00180 · DOI
  26. Chalazonitis, 2018, Enteric nervous system manifestations of neurodegenerative disease., Brain Res., 1693, 207, 10.1016/j.brainres.2018.01.011 · DOI
  27. Chao, 2009, Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson’s disease., J. Neuroimmunol., 216, 39, 10.1016/j.jneuroim.2009.09.003 · DOI
  28. Charidimou, 2014, White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?, Neurology, 82, 57, 10.1212/01.wnl.0000438225.02729.04 · DOI · Paper page
  29. Chen, 2010, Thrombin mediates severe neurovascular injury during ischemia., Stroke, 41, 2348, 10.1161/strokeaha.110.584920 · DOI
  30. Ching, 2018, Schwann cell-like differentiated adipose stem cells promote neurite outgrowth via secreted exosomes and RNA transfer., Stem Cell Res. Ther., 9, 10.1186/s13287-018-1017-8 · DOI
  31. Choi, 2011, Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model., Stroke, 42, 2595, 10.1161/strokeaha.111.620179 · DOI · Paper page
  32. Cole, 2019, Brain age and other bodily ’ages’: implications for neuropsychiatry., Mol. Psychiatry, 24, 266, 10.1038/s41380-018-0098-1 · DOI · Paper page
  33. Cole, 2006, Pain sensitivity and fMRI pain-related brain activity in Alzheimer’s disease., Brain, 129, 2957, 10.1093/brain/awl228 · DOI · Paper page
  34. Collins, 2012, Parasympathetic autonomic dysfunction is common in mild cognitive impairment., Neurobiol. Aging, 33, 2324, 10.1016/j.neurobiolaging.2011.11.017 · DOI
  35. Collins, 2013, Gut microbiota: intestinal bacteria influence brain activity in healthy humans., Nat. Rev. Gastroenterol. Hepatol., 10, 326, 10.1038/nrgastro.2013.76 · DOI
  36. Conte, 2013, Pathophysiology of somatosensory abnormalities in Parkinson disease., Nat. Rev. Neurol., 9, 687, 10.1038/nrneurol.2013.224 · DOI · Paper page
  37. Coon, 2018, Neuropathology of autonomic dysfunction in synucleinopathies., Mov. Disord., 33, 349, 10.1002/mds.27186 · DOI · Paper page
  38. Cordonnier, 2011, Brain microbleeds: more evidence, but still a clinical dilemma., Curr. Opin. Neurol., 24, 69, 10.1097/wco.0b013e328341f8c0 · DOI · Paper page
  39. Coulter, 2018, The ESCRT-III protein CHMP1A mediates secretion of sonic hedgehog on a distinctive subtype of extracellular vesicles., Cell Rep., 24, 973, 10.1016/j.celrep.2018.06.100 · DOI
  40. Crous-Bou, 2017, Alzheimer’s disease prevention: from risk factors to early intervention., Alzheimers Res. Ther., 9, 10.1186/s13195-017-0297-z · DOI · Paper page
  41. Dabby, 2006, Skin biopsy for assessment of autonomic denervation in Parkinson’s disease., J. Neural Transm., 113, 1169, 10.1007/s00702-005-0431-0 · DOI
  42. Dalle Pezze, 2014, Dynamic modelling of pathways to cellular senescence reveals strategies for targeted interventions., PLoS Comput. Biol., 10, 10.1371/journal.pcbi.1003728 · DOI · Paper page
  43. Davaapil, 2017, Conserved and novel functions of programmed cellular senescence during vertebrate development., Development, 144, 106, 10.1242/dev.138222 · DOI · Paper page
  44. Dearborn, 2017, Intracranial atherosclerosis and dementia: the atherosclerosis risk in communities (ARIC) study., Neurology, 88, 1556, 10.1212/wnl.0000000000003837 · DOI
  45. Dickinson, 2001, Why are strokes related to hypertension? Classic studies and hypotheses revisited., J. Hypertens., 19, 1515, 10.1097/00004872-200109000-00001 · DOI
  46. Dietzel, 2018, Does atrial fibrillation cause cognitive decline and dementia?, Europace, 20, 408, 10.1093/europace/eux031 · DOI
  47. Dirnagl, 1997, Metabolic aspects of neurovascular coupling., Adv. Exp. Med. Biol., 413, 155, 10.1007/978-1-4899-0056-2_17 · DOI
  48. Dobbs, 1999, Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism., Acta Neurol. Scand., 100, 34, 10.1111/j.1600-0404.1999.tb00721.x · DOI · Paper page
  49. Dolan, 2010, Atherosclerosis, dementia, and Alzheimer disease in the baltimore longitudinal study of aging cohort., Ann. Neurol., 68, 231, 10.1002/ana.22055 · DOI · Paper page
  50. Doty, 2017, Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate?, Lancet Neurol., 16, 478, 10.1016/s1474-4422(17)30123-0 · DOI · Paper page
  51. Driver-Dunckley, 2014, Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease., Parkinsonism Relat. Disord., 20, 1260, 10.1016/j.parkreldis.2014.08.006 · DOI
  52. Duarte, 2013, Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration., Biochim. Biophys. Acta, 1832, 527, 10.1016/j.bbadis.2013.01.008 · DOI
  53. Duarte, 2012, Insulin in central nervous system: more than just a peripheral hormone., J. Aging Res., 2012, 10.1155/2012/384017 · DOI · Paper page
  54. Duda, 1999, The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases., Exp. Neurol., 160, 515, 10.1006/exnr.1999.7228 · DOI
  55. Duran-Vilaregut, 2009, Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid., Neurotoxicology, 30, 136, 10.1016/j.neuro.2008.10.007 · DOI
  56. Eberle, 2012, Diabetic and metabolic programming: mechanisms altering the intrauterine milieu., ISRN Pediatr., 2012, 10.5402/2012/975685 · DOI
  57. Fan, 2017, Mechanisms of hippocampal aging and the potential for rejuvenation., Annu. Rev. Neurosci., 40, 251, 10.1146/annurev-neuro-072116-031357 · DOI
  58. Faraci, 1998, Regulation of the cerebral circulation: role of endothelium and potassium channels., Physiol. Rev., 78, 53, 10.1152/physrev.1998.78.1.53 · DOI · Paper page
  59. Fevrier, 2004, Cells release prions in association with exosomes., Proc. Natl. Acad. Sci. U.S.A., 101, 9683, 10.1073/pnas.0308413101 · DOI · Paper page
  60. Figueira, 2016, NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls., Mol. Biosyst., 12, 2562, 10.1039/c6mb00233a · DOI
  61. Fleitas, 2018, proBDNF is modified by advanced glycation end products in Alzheimer’s disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing., Mol. Brain, 11, 10.1186/s13041-018-0411-6 · DOI · Paper page
  62. Gan, 2018, Converging pathways in neurodegeneration, from genetics to mechanisms., Nat. Neurosci., 21, 1300, 10.1038/s41593-018-0237-7 · DOI · Paper page
  63. Gariepy, 2011, Obesity and the risk of disability in a 12-year cohort study: the role of psychological distress., Soc. Psychiatry Psychiatr. Epidemiol., 46, 1173, 10.1007/s00127-010-0284-1 · DOI
  64. Garner, 2017, Introducing therioepistemology: the study of how knowledge is gained from animal research., Lab Anim., 46, 103, 10.1038/laban.1224 · DOI
  65. Gensollen, 2016, How colonization by microbiota in early life shapes the immune system., Science, 352, 539, 10.1126/science.aad9378 · DOI · Paper page
  66. Girouard, 2006, Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease., J. Appl. Physiol., 100, 328, 10.1152/japplphysiol.00966.2005 · DOI · Paper page
  67. Gitler, 2017, Neurodegenerative disease: models, mechanisms, and a new hope., Dis. Model Mech., 10, 499, 10.1242/dmm.030205 · DOI · Paper page
  68. Graves, 2017, Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long-term warfarin., Am. Heart J., 188, 93, 10.1016/j.ahj.2017.02.026 · doi:10.1016/j.ahj.2017.02.026
  69. Grey, 2015, Acceleration of alpha-synuclein aggregation by exosomes., J. Biol. Chem., 290, 2969, 10.1074/jbc.m114.585703 · DOI · Paper page
  70. Grunert, 2013, Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients., Orphanet J. Rare Dis., 8, 10.1186/1750-1172-8-6 · DOI · Paper page
  71. Gutierrez Becker, 2018, Gaussian process uncertainty in age estimation as a measure of brain abnormality., Neuroimage, 175, 246, 10.1016/j.neuroimage.2018.03.075 · DOI
  72. Hallene, 2006, Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations., Neuroscience, 142, 267, 10.1016/j.neuroscience.2006.06.017 · DOI
  73. Helzner, 2009, Contribution of vascular risk factors to the progression in Alzheimer disease., Arch. Neurol., 66, 343, 10.1001/archneur.66.3.343 · DOI · Paper page
  74. Hill, 2015, Microbial-generated amyloids and Alzheimer’s disease (AD)., Front. Aging Neurosci., 7, 10.3389/fnagi.2015.00009 · DOI · Paper page
  75. Hofman, 1997, Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the rotterdam Study., Lancet, 349, 151, 10.1016/s0140-6736(96)09328-2 · DOI · Paper page
  76. Holm, 2018, Extracellular vesicles: multimodal envoys in neural maintenance and repair., Trends Neurosci., 41, 360, 10.1016/j.tins.2018.03.006 · DOI · Paper page
  77. Houlden, 2016, Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production., Brain Behav. Immun., 57, 10, 10.1016/j.bbi.2016.04.003 · DOI · Paper page
  78. Howitt, 2016, Exosomes in the pathology of neurodegenerative diseases., J. Biol. Chem., 291, 26589, 10.1074/jbc.r116.757955 · DOI · Paper page
  79. Hryhorczuk, 2013, Metabolic disturbances connecting obesity and depression., Front. Neurosci., 7, 10.3389/fnins.2013.00177 · DOI · Paper page
  80. Hsu, 2017, Primary and secondary prevention trials in Alzheimer disease: looking back, Moving Forward., Curr. Alzheimer Res., 14, 426, 10.2174/1567205013666160930112125 · DOI · Paper page
  81. Hufeldt, 2010, Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors., Comp. Med., 60, 336
  82. Iadecola, 2013, The pathobiology of vascular dementia., Neuron, 80, 844, 10.1016/j.neuron.2013.10.008 · DOI · Paper page
  83. Idiaquez, 2011, Autonomic dysfunction in neurodegenerative dementias., J. Neurol. Sci., 305, 22, 10.1016/j.jns.2011.02.033 · DOI
  84. 2002, Constitution of the World Health Organization. 1946., Bull. World Health Organ, 80, 983
  85. Jellinger, 2010, Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases., Neurodegener. Dis., 7, 112, 10.1159/000285518 · DOI
  86. Jia, 2018, Exosomes derived from high-glucose-stimulated schwann cells promote development of diabetic peripheral neuropathy., FASEB J, 10.1096/fj.201800597R · DOI
  87. Joachim, 1989, Amyloid beta-protein deposition in tissues other than brain in Alzheimer’s disease., Nature, 341, 226, 10.1038/341226a0 · DOI · Paper page
  88. Kalaria, 2010, Vascular basis for brain degeneration: faltering controls and risk factors for dementia., Nutr. Rev., S74, 10.1111/j.1753-4887.2010.00352.x · DOI · Paper page
  89. Kim, 2018, Distinct amyloid precursor protein processing machineries of the olfactory system., Biochem. Biophys. Res. Commun., 495, 533, 10.1016/j.bbrc.2017.10.153 · DOI
  90. Kim, 2016, Vasculo-neuronal coupling: retrograde vascular communication to brain neurons., J. Neurosci., 36, 12624, 10.1523/jneurosci.1300-16.2016 · DOI
  91. Klein, 2017, Prevention of epilepsy: should we be avoiding clinical trials?, Epilepsy Behav, 72, 188, 10.1016/j.yebeh.2017.05.024 · DOI
  92. Koles, 2012, Mechanism of evenness interrupted (Evi)-exosome release at synaptic boutons., J. Biol. Chem., 287, 16820, 10.1074/jbc.m112.342667 · DOI · Paper page
  93. Korhonen, 2018, 3D human brain cell models: new frontiers in disease understanding and drug discovery for neurodegenerative diseases., Neurochem. Int., 120, 191, 10.1016/j.neuint.2018.08.012 · DOI
  94. Kountouras, 2009, Eradication of helicobacter pylori may be beneficial in the management of Alzheimer’s disease., J. Neurol., 256, 758, 10.1007/s00415-009-5011-z · DOI · Paper page
  95. Kupsky, 1987, Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells., Neurology, 37, 1253, 10.1212/WNL.37.7.1253 · DOI · Paper page
  96. Lachenal, 2011, Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity., Mol. Cell. Neurosci., 46, 409, 10.1016/j.mcn.2010.11.004 · DOI · Paper page
  97. Larsson, 2018, Does treating vascular risk factors prevent dementia and Alzheimer’s disease? a systematic review and meta-analysis., J. Alzheimers Dis., 64, 657, 10.3233/jad-180288 · DOI · Paper page
  98. Lebouvier, 2009, The second brain and Parkinson’s disease., Eur. J. Neurosci., 30, 735, 10.1111/j.1460-9568.2009.06873.x · DOI · Paper page
  99. Lee, 2017, Medical big data: promise and challenges., Kidney Res. Clin. Pract., 36, 3, 10.23876/j.krcp.2017.36.1.3 · DOI · Paper page
  100. Lee, 2014, Synergistic effects of ischemia and beta-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment., JAMA Psychiatry, 71, 412, 10.1001/jamapsychiatry.2013.4506 · DOI
  101. Lee, 2018, Reciprocal control of excitatory synapse numbers by Wnt and Wnt inhibitor PRR7 secreted on exosomes., Nat. Commun., 9, 10.1038/s41467-018-05858-2 · DOI
  102. Lema Tome, 2013, Inflammation and alpha-synuclein’s prion-like behavior in Parkinson’s disease–is there a link?, Mol. Neurobiol, 47, 561, 10.1007/s12035-012-8267-8 · DOI · Paper page
  103. Li, 2017, Gut microbiota and atherosclerosis., Curr. Atheroscler. Rep., 19, 10.1007/s11883-017-0675-9 · DOI
  104. Li, 2018, In vivo evidence for the contribution of peripheral circulating inflammatory exosomes to neuroinflammation., J. Neuroinflammation, 15, 10.1186/s12974-017-1038-8 · DOI · Paper page
  105. Li, 1991, Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells., Cancer Res., 51, 2531
  106. Li, 2017, The gut microbiota and autism spectrum disorders., Front. Cell. Neurosci., 11, 10.3389/fncel.2017.00120 · DOI · Paper page
  107. Liddell, 2017, Are astrocytes the predominant cell type for activation of nrf2 in aging and neurodegeneration?, Antioxidants, 6, 10.3390/antiox6030065 · DOI · Paper page
  108. Lim, 2012, A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010., Lancet, 380, 2224, 10.1016/S0140-6736(12)61766-8 · DOI · Paper page
  109. Lloret-Villas, 2017, The impact of mathematical modeling in understanding the mechanisms underlying neurodegeneration: evolving dimensions and future directions., CPT Pharmacometrics Syst. Pharmacol., 6, 73, 10.1002/psp4.12155 · DOI
  110. Lopez-Verrilli, 2016, Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth., Neuroscience, 320, 129, 10.1016/j.neuroscience.2016.01.061 · DOI · Paper page
  111. Lusis, 2000, Atherosclerosis., Nature, 407, 233, 10.1038/35025203 · DOI · Paper page
  112. Maldonado, 2016, Lipopolysaccharide modification in Gram-negative bacteria during chronic infection., FEMS Microbiol. Rev., 40, 480, 10.1093/femsre/fuw007 · DOI · Paper page
  113. Manwani, 2013, Differential effects of aging and sex on stroke induced inflammation across the lifespan., Exp. Neurol., 249, 120, 10.1016/j.expneurol.2013.08.011 · DOI · Paper page
  114. Marin, 2018, Olfactory dysfunction in neurodegenerative diseases., Curr. Allergy Asthma Rep., 18, 10.1007/s11882-018-0796-4 · DOI · Paper page
  115. Mattson, 1999, Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer’s and Parkinson’s diseases., Ann. N. Y. Acad. Sci., 893, 154, 10.1111/j.1749-6632.1999.tb07824.x · DOI · Paper page
  116. Mergenthaler, 2004, Pathophysiology of stroke: lessons from animal models., Metab. Brain Dis., 19, 151, 10.1023/b:mebr.0000043966.46964.e6 · DOI · Paper page
  117. Mergenthaler, 2012, Do stroke models model stroke?, Dis Model Mech, 5, 718, 10.1242/dmm.010033 · DOI
  118. Mills, 2007, Biomarkers of cerebrovascular disease in dementia., Br. J. Radiol., 2, S128, 10.1259/bjr/79217686 · DOI
  119. Minamiyama, 2004, Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy., Hum. Mol. Genet., 13, 1183, 10.1093/hmg/ddh131 · DOI · Paper page
  120. Mondadori, 2006, Enhanced brain activity may precede the diagnosis of Alzheimer’s disease by 30 years., Brain, 129, 2908, 10.1093/brain/awl266 · DOI
  121. Moore, 2008, The hemo-neural hypothesis: on the role of blood flow in information processing., J. Neurophysiol., 99, 2035, 10.1152/jn.01366.2006 · DOI · Paper page
  122. Morsi, 2018, A shared comparison of diabetes mellitus and neurodegenerative disorders., J. Cell Biochem., 119, 1249, 10.1002/jcb.26261 · DOI
  123. Mukherjee, 2019, A microglial signature directing human aging and neurodegeneration-related gene networks., Front. Neurosci., 13, 10.3389/fnins.2019.00002 · DOI
  124. Nishtala, 2018, Atrial fibrillation and cognitive decline in the framingham heart study., Heart Rhythm, 15, 166, 10.1016/j.hrthm.2017.09.036 · DOI
  125. Nolano, 2008, Sensory deficit in Parkinson’s disease: evidence of a cutaneous denervation., Brain, 131, 1903, 10.1093/brain/awn102 · DOI · Paper page
  126. Olsson, 2016, CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis., Lancet Neurol., 15, 673, 10.1016/s1474-4422(16)00070-3 · DOI · Paper page
  127. Olufadi, 2008, Clinical and laboratory diagnosis of the metabolic syndrome., J. Clin. Pathol., 61, 697, 10.1136/jcp.2007.048363 · DOI · Paper page
  128. Oost, 2018, Targeting senescence to delay progression of multiple sclerosis., J. Mol. Med., 96, 1153, 10.1007/s00109-018-1686-x · DOI
  129. Org, 2017, Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort., Genome Biol., 18, 10.1186/s13059-017-1194-2 · DOI · Paper page
  130. Orimo, 2005, Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2., Mov. Disord., 20, 1350, 10.1002/mds.20594 · DOI
  131. Orock, 2019, Age-related cognitive impairment: role of reduced synaptobrevin-2 levels in memory and synaptic plasticity deficits., J. Gerontol. A Biol. Sci. Med. Sci., 10.1093/gerona/glz013 · DOI
  132. Ozkor, 2011, Endothelium-derived hyperpolarizing factor and vascular function., Cardiol. Res. Pract., 2011, 10.4061/2011/156146 · DOI
  133. Park, 2017, Metagenome analysis of bodily microbiota in a mouse model of Alzheimer disease using bacteria-derived membrane vesicles in blood., Exp. Neurobiol., 26, 369, 10.5607/en.2017.26.6.369 · DOI
  134. Pellegrinelli, 2018, Adipocyte-secreted BMP8b mediates adrenergic-induced remodeling of the neuro-vascular network in adipose tissue., Nat. Commun., 9, 10.1038/s41467-018-07453-x · DOI
  135. Percie du Sert, 2017, The improve guidelines (Ischaemia models: procedural refinements of in vivo experiments)., J. Cereb. Blood Flow Metab., 37, 3488, 10.1177/0271678x17709185 · DOI · Paper page
  136. Petcu, 2008, Cellular and molecular events underlying the dysregulated response of the aged brain to stroke: a mini-review., Gerontology, 54, 6, 10.1159/000112845 · DOI
  137. Poels, 2012, Arterial stiffness and cerebral small vessel disease: the rotterdam scan study., Stroke, 43, 2637, 10.1161/strokeaha.111.642264 · DOI · Paper page
  138. Polanco, 2016, Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold-dependent manner., J. Biol. Chem., 291, 12445, 10.1074/jbc.m115.709485 · DOI · Paper page
  139. Popa-Wagner, 2011, Perturbed cellular response to brain injury during aging., Ageing Res. Rev., 10, 71, 10.1016/j.arr.2009.10.008 · DOI
  140. Popa-Wagner, 2007, The response of the aged brain to stroke: too much, too soon?, Curr. Neurovasc. Res, 4, 216, 10.2174/156720207781387213 · DOI
  141. Popa-Wagner, 2010, Pathophysiology of the vascular wall and its relevance for cerebrovascular disorders in aged rodents., Curr. Neurovasc. Res., 7, 251, 10.2174/156720210792231813 · DOI
  142. Postuma, 2015, REM sleep behavior disorder and neuropathology in Parkinson’s disease., Mov. Disord., 30, 1413, 10.1002/mds.26347 · DOI · Paper page
  143. Przedborski, 2003, Neurodegeneration: what is it and where are we?, J. Clin. Invest., 111, 3, 10.1172/JCI200317522 · DOI · Paper page
  144. Purves, 1988, Body and Brain: A Trophic Theory of Neural Connections.
  145. Qureshi, 2013, Towards a ’systems’-level understanding of the nervous system and its disorders., Trends Neurosci., 36, 674, 10.1016/j.tins.2013.07.003 · DOI
  146. Racosta, 2015, Autonomic dysfunction in multiple sclerosis., Auton. Neurosci., 193, 1, 10.1016/j.autneu.2015.06.001 · DOI
  147. Ramirez, 2015, Visible virchow-robin spaces on magnetic resonance imaging of Alzheimer’s disease patients and normal elderly from the sunnybrook dementia study., J. Alzheimers. Dis., 43, 415, 10.3233/jad-132528 · DOI · Paper page
  148. Ransohoff, 2018, All (animal) models (of neurodegeneration) are wrong. Are they also useful?, J. Exp. Med., 215, 2955, 10.1084/jem.20182042 · DOI · Paper page
  149. Reichling, 2011, Pain and death: neurodegenerative disease mechanisms in the nociceptor., Ann. Neurol., 69, 13, 10.1002/ana.22351 · DOI
  150. Rios-Covian, 2016, Intestinal short chain fatty acids and their link with diet and human health., Front. Microbiol., 7, 10.3389/fmicb.2016.00185 · DOI · Paper page
  151. Ritzel, 2018, Aging alters the immunological response to ischemic stroke., Acta Neuropathol., 136, 89, 10.1007/s00401-018-1859-2 · DOI · Paper page
  152. Robbins, 2017, Human induced pluripotent stem cells as a research tool in Alzheimer’s disease., Psychol. Med., 47, 2587, 10.1017/s0033291717002124 · DOI
  153. Roberts, 2018, The human brain microbiome; there are bacteria in our brains!, Conference Report at the Society for Neuroscience Meeting
  154. Rogers, 1984, Senescent microstructural changes in rat cerebellum., Brain Res., 292, 23, 10.1016/0006-8993(84)90886-2 · DOI
  155. Roquer, 2009, Endothelial dysfunction, vascular disease and stroke: the ARTICO study., Cerebrovasc. Dis., 25, 10.1159/000200439 · DOI
  156. Roriz-Filho, 2009, (Pre)diabetes, brain aging, and cognition., Biochim. Biophys. Acta, 1792, 432, 10.1016/j.bbadis.2008.12.003 · DOI · Paper page
  157. Roy, 1890, On the regulation of the blood-supply of the brain., J. Physiol., 11, 85, 10.1113/jphysiol.1890.sp000321 · DOI · Paper page
  158. Ryden, 2019, Atrial fibrillation increases the risk of dementia amongst older adults even in the absence of stroke., J. Intern. Med., 286, 101, 10.1111/joim.12902 · DOI
  159. Sadoshima, 1983, Mechanisms of protection against stroke in stroke-prone spontaneously hypertensive rats., Am. J. Physiol., 244, H406
  160. Saha, 2000, Induction of neuronal death by alpha-synuclein., Eur. J. Neurosci., 12, 3073, 10.1046/j.1460-9568.2000.00210.x · DOI · Paper page
  161. Sanchez-Tapia, 2017, Nopal (Opuntia ficus indica) protects from metabolic endotoxemia by modifying gut microbiota in obese rats fed high fat/sucrose diet., Sci. Rep., 7, 10.1038/s41598-017-05096-4 · DOI
  162. Sanguinetti, 2018, Microbiome-metabolome signatures in mice genetically prone to develop dementia, fed a normal or fatty diet., Sci. Rep., 8, 10.1038/s41598-018-23261-1 · DOI
  163. Schmidt, 1994, NO at work., Cell, 78, 919, 10.1016/0092-8674(94)90267-4 · DOI · Paper page
  164. Seib, 2015, Neurogenesis in the normal ageing hippocampus: a mini-review., Gerontology, 61, 327, 10.1159/000368575 · DOI
  165. Selvarajah, 2009, Potential surrogate markers of cerebral microvascular angiopathy in asymptomatic subjects at risk of stroke., Eur. Radiol., 19, 1011, 10.1007/s00330-008-1202-8 · DOI
  166. Shankle, 1993, Studies of the enteric nervous system in Alzheimer disease and other dementias of the elderly: enteric neurons in Alzheimer disease., Mod. Pathol., 6, 10
  167. Shen, 2017, Alzheimer’s disease histological and behavioral manifestations in transgenic mice correlate with specific gut microbiome state., J. Alzheimers. Dis., 56, 385, 10.3233/jad-160884 · DOI · Paper page
  168. Shiue, 2019, Mesenchymal stem cell exosomes as a cell-free therapy for nerve injury-induced pain in rats., Pain, 160, 210, 10.1097/j.pain.0000000000001395 · DOI · Paper page
  169. Silvestrini, 2006, Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease., Stroke, 37, 1010, 10.1161/01.str.0000206439.62025.97 · DOI · Paper page
  170. Simeoli, 2017, Exosomal cargo including microRNA regulates sensory neuron to macrophage communication after nerve trauma., Nat. Commun., 8, 10.1038/s41467-017-01841-5 · DOI · Paper page
  171. Singh, 2016, Microbiota dysbiosis controls the neuroinflammatory response after stroke., J. Neurosci., 36, 7428, 10.1523/jneurosci.1114-16.2016 · DOI · Paper page
  172. Singh, 2018, The gut microbiome primes a cerebroprotective immune response after stroke., J. Cereb. Blood Flow Metab., 38, 1293, 10.1177/0271678x18780130 · DOI · Paper page
  173. Smith, 1999, Altered brain activation in cognitively intact individuals at high risk for Alzheimer’s disease., Neurology, 53, 1391, 10.1212/WNL.53.7.1391 · DOI · Paper page
  174. Snowdon, 1997, Brain infarction and the clinical expression of Alzheimer disease. The nun study., JAMA, 277, 813, 10.1001/jama.277.10.813 · doi:10.1001/jama.277.10.813 · Paper page
  175. Song, 2007, Clinical significance of silent cerebral infarctions in patients with Alzheimer disease., Cogn. Behav. Neurol., 20, 93, 10.1097/wnn.0b013e31805d859e · DOI
  176. Stanley, 2018, An insight into intestinal mucosal microbiota disruption after stroke., Sci. Rep., 8, 10.1038/s41598-017-18904-8 · DOI · Paper page
  177. Syeda, 2018, Bioactive food abates metabolic and synaptic alterations by modulation of gut microbiota in a mouse model of Alzheimer’s disease., J. Alzheimers. Dis., 66, 1657, 10.3233/jad-180556 · DOI · Paper page
  178. Szablewski, 2018, Human gut microbiota in health and Alzheimer’s disease., J. Alzheimers. Dis., 62, 549, 10.3233/jad-170908 · DOI
  179. Taguchi, 2016, Brain region-dependent differential expression of alpha-synuclein., J. Comp. Neurol., 524, 1236, 10.1002/cne.23901 · DOI · Paper page
  180. Thery, 2018, Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines., J. Extracell. Vesicles, 7, 10.1080/20013078.2018.1535750 · DOI · Paper page
  181. Tian, 2014, Endothelial cell senescence and age-related vascular diseases., J. Genet. Genom., 41, 485, 10.1016/j.jgg.2014.08.001 · DOI
  182. Toledo, 2013, Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the national Alzheimer’s coordinating centre., Brain, 136, 2697, 10.1093/brain/awt188 · DOI · Paper page
  183. Torres-Fuentes, 2017, The microbiota-gut-brain axis in obesity., Lancet Gastroenterol. Hepatol., 2, 747, 10.1016/S2468-1253(17)30147-4 · DOI · Paper page
  184. Turnquist, 2016, p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration., Cell Death. Differ., 23, 1515, 10.1038/cdd.2016.37 · DOI · Paper page
  185. van Oijen, 2007, Atherosclerosis and risk for dementia., Ann. Neurol., 61, 403, 10.1002/ana.21073 · DOI · Paper page
  186. VanGuilder, 2010, Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome., J. Neurochem., 113, 1577, 10.1111/j.1471-4159.2010.06719.x · DOI
  187. Verdu, 2015, Novel players in coeliac disease pathogenesis: role of the gut microbiota., Nat. Rev. Gastroenterol. Hepatol., 12, 497, 10.1038/nrgastro.2015.90 · DOI · Paper page
  188. Vicente Miranda, 2016, Glycation in Parkinson’s disease and Alzheimer’s disease., Mov. Disord., 31, 782, 10.1002/mds.26566 · DOI
  189. Villaran, 2010, Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson‘s disease., J. Neurochem., 114, 1687, 10.1111/j.1471-4159.2010.06879.x · DOI · Paper page
  190. Villringer, 1997, Understanding functional neuroimaging methods based on neurovascular coupling., Adv. Exp. Med. Biol., 413, 177, 10.1007/978-1-4899-0056-2_20 · DOI
  191. Wakabayashi, 2010, Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain., Acta Neuropathol., 120, 1, 10.1007/s00401-010-0706-x · DOI · Paper page
  192. Wakabayashi, 1990, Parkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system., Acta Neuropathol., 79, 581, 10.1007/bf00294234 · DOI · Paper page
  193. Walsh, 2002, Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo., Nature, 416, 535, 10.1038/416535a · DOI · Paper page
  194. Walton, 2019, Unknown fates of (brain) oxidation or UFO: close encounters with neuronal senescence., Free Radic Biol. Med., 134, 695, 10.1016/j.freeradbiomed.2019.01.012 · DOI
  195. Wang, 2012, Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder., Dig. Dis. Sci., 57, 2096, 10.1007/s10620-012-2167-7 · DOI · Paper page
  196. Wang, 2007, Changes in hippocampal synapses and learning-memory abilities in age-increasing rats and effects of tetrahydroxystilbene glucoside in aged rats., Neuroscience, 149, 739, 10.1016/j.neuroscience.2007.07.065 · DOI
  197. Wang, 2010, Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-beta oligomerization in rats., J. Alzheimers Dis., 21, 813, 10.3233/jad-2010-100216 · DOI
  198. Wardlaw, 2013, Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration., Lancet Neurol., 12, 822, 10.1016/S1474-4422(13)70124-8 · DOI · Paper page
  199. Wendell, 2012, Carotid atherosclerosis and prospective risk of dementia., Stroke, 43, 3319, 10.1161/strokeaha.112.672527 · DOI · Paper page
  200. Wenk, 2000, Regional changes in the hippocampal density of AMPA and NMDA receptors across the lifespan of the rat., Brain Res., 885, 1, 10.1016/s0006-8993(00)02792-x · DOI

200 of 213 shown

Cited by

See all 79

Metadata

Authors
Castillo, X., Castro-Obregón, S., Gutiérrez-Becker, B., Gutiérrez-Ospina, G., Karalis, N., Khalil, A. A., Lopez-Noguerola, J. S., Rodríguez, L. L., Martínez-Martínez, E., Perez-Cruz, C., Pérez-Velázquez, J., Piña, A. L., Rubio, K., García, H. P. S., Syeda, T., Vanoye-Carlo, A., Villringer, A., Winek, K., & Zille, M.
Venue
Frontiers in Neuroscience
Published
2019-07-24
Volume
13
Pages
728-728
ISSN
1662-453X (ISSN-L)
OpenAlex
W2963701142
Cited by
79
References
122
FWCI
5.00
Type
journal article
Language
en
Open access
gold
Funders
Bundesministerium für Bildung und Forschung

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Re-thinking the Etiological Framework of Neurodegeneration. https://app.cochat.ai/papers/10.3389/fnins.2019.00728
The paper
Castillo, X., Castro-Obregón, S., Gutiérrez-Becker, B., Gutiérrez-Ospina, G., Karalis, N., Khalil, A. A., Lopez-Noguerola, J. S., Rodríguez, L. L., Martínez-Martínez, E., Perez-Cruz, C., Pérez-Velázquez, J., Piña, A. L., Rubio, K., García, H. P. S., Syeda, T., Vanoye-Carlo, A., Villringer, A., Winek, K., & Zille, M. (2019). Re-thinking the Etiological Framework of Neurodegeneration. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2019.00728

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.